DC Field | Value | Language |
dc.contributor.author | Carpenco, Ecaterina | |
dc.date.accessioned | 2019-09-11T13:14:01Z | |
dc.date.available | 2019-09-11T13:14:01Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | CARPENCO, Ecaterina. Tumor associated macrophages in breast cancer. In: The Moldovan Medical Journal. 2019, vol. 62, no 1, pp. 24-27. ISSN 2537-6373. DOI: 10.5281/zenodo.2590003 | en_US |
dc.identifier.issn | 2537-6373 | |
dc.identifier.issn | 2537-6381 | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/6758 | |
dc.identifier.uri | https://doi.org/10.5281/zenodo.2590003 | |
dc.identifier.uri | http://moldmedjournal.md/wp-content/uploads/2019/03/Moldovan-Med-J-Vol-62-No-1-Full-Issue.pdf | |
dc.description | Department of Histology, Cytology and Embriology, Laboratory of Morphology, Nicolae Testemitsanu State University of Medicine and Pharmacy, Chisinau, the Republic of Moldova | en_US |
dc.description.abstract | Background: Cancer research was focused on the studying of proper tumor cells for a long time. Despite the huge progress, there are still a lot of questions,
that’s why new molecular markers must be identified. These could reveal new information about tumorigenesis.
Material and methods: 15 cases of ductal invasive breast carcinomas have been analyzed and researched on tumor associated macrophages via
immunohistochemistry. CD68 was used as a macrophage marker and CD68+ cells were evaluated in tumor nest and peritumoral area, as well as hormone
receptors (ER, PR) and HER2 protein.
Results: Most of tumors (10 cases out of 15/ 66.7%) were moderately differentiated (G2). The mean and std. error of mean of intratumoral CD68+ cells
were 2.0±0.2, of peritumoral CD68+ cells – 1.4±0.2. Intratumoral CD68+ cells registered higher scores than those located in the peritumoral area.
Conclusions: CD68+ cells are more likely to be present in the tumor nest rather than in the peritumoral area. This research did not establish any significant
correlations between intratumoral and peritumoral CD68+ cells and patients’ age, tumor grade, expression of ER and PR. The content of peritumoral
CD68+ cells inversely correlated with the number of HER2+ carcinoma cells. | en_US |
dc.language.iso | en | en_US |
dc.publisher | The Scientific Medical Association of the Republic of Moldova | en_US |
dc.relation.ispartof | The Moldovan Medical Journal | |
dc.subject | breast cancer | en_US |
dc.subject | tumor associated macrophages | en_US |
dc.subject | CD68 | en_US |
dc.subject | ER | en_US |
dc.subject | PR | en_US |
dc.subject | HER2 | en_US |
dc.subject.ddc | UDC: 618.19-006.6-074/-078:577.27 | |
dc.subject.mesh | Breast Neoplasms --immunology | en_US |
dc.subject.mesh | Antigens, CD --immunology | en_US |
dc.subject.mesh | Macrophages | en_US |
dc.subject.mesh | Triple Negative Breast Neoplasms--complications | en_US |
dc.subject.mesh | Immunohistochemistry | en_US |
dc.subject.mesh | Histological Techniques | en_US |
dc.title | Tumor associated macrophages in breast cancer | en_US |
dc.type | Article | en_US |
Appears in Collections: | The Moldovan Medical Journal, Vol. 62, No 1, March 2019
|